Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow

作者：Sharma Shruti; Kumar Sanjiv; Sud Neetu; Wiseman Dean A; Tian Jing; Rehmani Imran; Datar Sanjeev; Oishi Peter; Fratz Sohrab; Venema Richard C; Fineman Jeffrey R; Black Stephen M^*

来源：Vascular Pharmacology, 2009, 51(5-6): 359-364.

DOI：10.1016/j.vph.2009.09.005

• Pulmonary hypertension
• Argininosuccinate lyase
• Argininosuccinate synthetase
• Cationic amino acid transporter-1
• Arginase

Previous studies demonstrate impaired nitric oxide (NO) signaling in children and animal models with congenital heart defects and increased pulmonary blood flow. However, the molecular mechanisms underlying these alterations remain incompletely understood. The purpose of this study was to determine if early changes in arginine metabolic pathways could play a role in the reduced NO signaling demonstrated in our lamb model of congenital heart disease with increased pulmonary blood flow (Shunt lambs). The activities of the arginine recycling enzymes, argininosuccinate synthetase (ASS) and argininosuccinate lyase (ASL) were both decreased in lung tissues of Shunt lambs while arginase activity was increased. Associated with these alterations, lung L-arginine levels were decreased. These changes correlated with an increase in NO synthase-derived reactive oxygen species (ROS) generation. This study provides further insights into the molecular mechanisms leading to decreased NO signaling in Shunt lambs and suggests that altered arginine metabolism may play a role in the development of the endothelial dysfunction associated with pulmonary hypertension secondary to increased pulmonary blood flow.

• 出版日期2009-12